Amanote Research
Register
Sign In
FDA Approves First Biosimilar to Treat Cancer
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2017-139
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
October 5, 2017
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
FDA Approves Kadcyla for Breast Cancer
Cancer Discovery
Oncology
FDA Approves Test for TB
Infection Control and Hospital Epidemiology
Epidemiology
Infectious Diseases
Microbiology
FDA-Approved Biosimilar Insulin
Journal of diabetes science and technology
Internal Medicine
Endocrinology
Bioengineering
Biomedical Engineering
Metabolism
Diabetes
Correction To: FDA and EMA Biosimilar Approvals
Journal of General Internal Medicine
Internal Medicine
FDA Approves Breakthrough Immunotherapy for Patients With Non-Small-Cell Lung Cancer
Cancer
Cancer Research
Oncology
FDA Approves New Drug to Reduce Risk of Stroke
Circulation
Cardiovascular Medicine
Physiology
Cardiology
FDA Approves Second Vaccine to Protect Children Against Rotaviruses
Microbe
Microbiology
FDA-approves the First Therapy in 2018 for the Seizures Associated With Dravet Syndrome
NeuroPharmac Journal
Possible FDA-approved Drugs to Treat Ebola Virus Infection
Infectious Diseases of Poverty
Medicine
Environmental
Public Health
Infectious Diseases
Occupational Health